FHTX (STOCKS)
Foghorn Therapeutics Inc. Common Stock
$4.110000
-0.070000 (-1.67%)
Prev close: $4.180000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Biotechnology
- CEO
- Adrian Gottschalk
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $241.61M
- Employees
- 112
- P/E (TTM)
- -3.41
- P/B (TTM)
- -3.16
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
7
Strong Buy
8
Buy
1
Hold
0
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Mar 2026 (Q1)
|
$-0.29 | $-0.31 | +0.0211 | +6.78% |
|
Dec 2025 (Q4)
|
$-0.34 | $-0.25 | -0.0877 | -34.76% |
|
Sep 2025 (Q3)
|
$-0.25 | $-0.34 | +0.0895 | +26.36% |
|
Jun 2025 (Q2)
|
$-0.28 | $-0.37 | +0.0857 | +23.43% |
Financial Statements
| Revenues | $28.22M |
| Benefits Costs and Expenses | $0.00 |
| Costs And Expenses | $113.27M |
| Nonoperating Income/Loss | $9.73M |
| Operating Expenses | $113.27M |
| Research and Development | $82.10M |
| Other Operating Expenses | $31.17M |
| Operating Income/Loss | -$85.05M |
| Income/Loss From Continuing Operations After Tax | -$75.32M |
| Income/Loss From Continuing Operations Before Tax | $2.73M |
| Net Income/Loss | -$75.32M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$75.32M |
| Net Income/Loss Available To Common Stockholders, Basic | -$75.32M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$1.16 |
| Diluted Earnings Per Share | -$1.16 |
| Basic Average Shares | 195,575,823 |
| Diluted Average Shares | 195,575,823 |
| Assets | $222.17M |
| Current Assets | $188.06M |
| Noncurrent Assets | $34.10M |
| Liabilities | $298.58M |
| Current Liabilities | $64.40M |
| Accounts Payable | $3.32M |
| Wages | $1.51M |
| Other Current Liabilities | $59.57M |
| Noncurrent Liabilities | $234.17M |
| Equity | -$76.41M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | -$76.41M |
| Liabilities And Equity | $222.17M |
| Net Cash Flow From Operating Activities | -$87.40M |
| Net Cash Flow From Operating Activities, Continuing | -$87.40M |
| Net Cash Flow From Investing Activities | $64.92M |
| Net Cash Flow From Investing Activities, Continuing | $64.92M |
| Net Cash Flow From Financing Activities | $50.66M |
| Net Cash Flow From Financing Activities, Continuing | $50.66M |
| Net Cash Flow | $28.18M |
| Net Cash Flow, Continuing | $28.18M |
| Comprehensive Income/Loss | -$75.41M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$75.47M |
| Other Comprehensive Income/Loss | -$57.48M |
| Other Comprehensive Income/Loss Attributable To Parent | -$147.00K |